advancing innovation to save lives

New fact sheet series: R&D across health areas

GHTC released a new fact sheet series that examines the role of R&D in driving progress across different global health areas. Each fact sheet provides an overview of R&D for a specific disease or health area, including examples of past research successes, key missing tools, promising products in development, and how the US government is contributing to R&D efforts.
Learn More

New resource: COVID-19 R&D Tracker

GHTC has created a new resource tracking the current state of R&D efforts to combat COVID-19. The tracker, which will be updated regularly, includes information on R&D efforts supported by the US government, multilateral institutions, and GHTC member organizations.

Member Spotlight: Washington Global Health Alliance

The Washington Global Health Alliance (WGHA) connects & informs Washington's global health community. Subscribe to its Field Notes newsletter for the inside scoop on global health's movers and shakers in Washington state. 
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more

PATH/Matthew Dakin
GHTC joins civil society in urging G20 leaders to strengthen R&D to meet critical health challenges

GHTC joined civil society in urging G20 policymakers at today’s C20 meeting with the G20 Health Working Group to strengthen R&D to meet urgent health challenges, including achieving universal health coverage and combating antimicrobial resistance and other health threats. 

Learn More

PATH/ Patrick McKern
GHTC joins InterAction in calling on G7 to prioritize health

GHTC joined the humanitarian and development coalition InterAction in calling on G7 foreign ministers to prioritize health on the 2020 G7 agenda. The coalition released a policy report, including a section on health co-authored by GHTC, which urges the G7 to investment in R&D for new health tools.

View All News & Events
PATH/Patrick McKern
Research Roundup: Study finds malaria drug helps improve COVID-19 patients, J&J and Moderna sign deals with US to produce coronavirus vaccines, and FDA authorizes 15-minute coronavirus test
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Read More
PATH/Patrick McKern
Research Roundup: Coronavirus not mutating quickly, FDA authorizes plasma treatment for COVID-19, and new COVID-19 rapid diagnostic
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Read More
View Breakthroughs Blog

Our members work to improve health worldwide